ID   PSR2_PHYSO              Reviewed;         670 AA.
AC   E0W4V5;
DT   16-OCT-2019, integrated into UniProtKB/Swiss-Prot.
DT   02-NOV-2010, sequence version 1.
DT   07-APR-2021, entry version 35.
DE   RecName: Full=RxLR effector protein PSR2 {ECO:0000303|PubMed:21653195};
DE   AltName: Full=Avirulence homolog protein 146 {ECO:0000303|PubMed:21653195};
DE   AltName: Full=Suppressor of RNA silencing protein 2 {ECO:0000303|PubMed:23377181};
DE   Flags: Precursor;
GN   Name=PSR2 {ECO:0000303|PubMed:23377181};
GN   Synonyms=Avh146 {ECO:0000303|PubMed:21653195};
OS   Phytophthora sojae (Soybean stem and root rot agent) (Phytophthora
OS   megasperma f. sp. glycines).
OC   Eukaryota; Sar; Stramenopiles; Oomycota; Peronosporales; Peronosporaceae;
OC   Phytophthora.
OX   NCBI_TaxID=67593;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], IDENTIFICATION, AND DOMAIN.
RC   STRAIN=P7064, P7074, and P7076;
RX   PubMed=21653195; DOI=10.1105/tpc.111.086082;
RA   Wang Q., Han C., Ferreira A.O., Yu X., Ye W., Tripathy S., Kale S.D.,
RA   Gu B., Sheng Y., Sui Y., Wang X., Zhang Z., Cheng B., Dong S., Shan W.,
RA   Zheng X., Dou D., Tyler B.M., Wang Y.;
RT   "Transcriptional programming and functional interactions within the
RT   Phytophthora sojae RXLR effector repertoire.";
RL   Plant Cell 23:2064-2086(2011).
RN   [2]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=23377181; DOI=10.1038/ng.2525;
RA   Qiao Y., Liu L., Xiong Q., Flores C., Wong J., Shi J., Wang X., Liu X.,
RA   Xiang Q., Jiang S., Zhang F., Wang Y., Judelson H.S., Chen X., Ma W.;
RT   "Oomycete pathogens encode RNA silencing suppressors.";
RL   Nat. Genet. 45:330-333(2013).
RN   [3]
RP   FUNCTION, AND INDUCTION.
RX   PubMed=25387135; DOI=10.1094/mpmi-06-14-0190-r;
RA   Xiong Q., Ye W., Choi D., Wong J., Qiao Y., Tao K., Wang Y., Ma W.;
RT   "Phytophthora suppressor of RNA silencing 2 is a conserved RxLR effector
RT   that promotes infection in soybean and Arabidopsis thaliana.";
RL   Mol. Plant Microbe Interact. 27:1379-1389(2014).
RN   [4]
RP   FUNCTION, DOMAIN, AND INTERACTION WITH HOST DRB4.
RX   PubMed=30595554; DOI=10.1016/j.chom.2018.11.007;
RA   Hou Y., Zhai Y., Feng L., Karimi H.Z., Rutter B.D., Zeng L., Choi D.S.,
RA   Zhang B., Gu W., Chen X., Ye W., Innes R.W., Zhai J., Ma W.;
RT   "A Phytophthora Effector Suppresses Trans-Kingdom RNAi to Promote Disease
RT   Susceptibility.";
RL   Cell Host Microbe 25:153-165(2019).
RN   [5] {ECO:0007744|PDB:5GNC}
RP   X-RAY CRYSTALLOGRAPHY (2.80 ANGSTROMS) OF 59-670, DOMAIN, FUNCTION, AND
RP   MUTAGENESIS OF 79-LYS--ASP-126; 127-SER--ASN-217; 218-PRO--ASN-308;
RP   309-PRO--LYS-399; 400-GLU--ASN-492; 493-PRO--ALA-583 AND 584-PRO--GLY-670.
RX   PubMed=30926664; DOI=10.1073/pnas.1819481116;
RA   He J., Ye W., Choi D.S., Wu B., Zhai Y., Guo B., Duan S., Wang Y., Gan J.,
RA   Ma W., Ma J.;
RT   "Structural analysis of Phytophthora suppressor of RNA silencing 2 (PSR2)
RT   reveals a conserved modular fold contributing to virulence.";
RL   Proc. Natl. Acad. Sci. U.S.A. 116:8054-8059(2019).
CC   -!- FUNCTION: Secreted effector that possesses RNA silencing suppression
CC       activity by inhibiting the biogenesis of small RNAs in the host plant
CC       to promote enhanced susceptibility of host to the pathogen during
CC       infection (PubMed:23377181, PubMed:25387135, PubMed:30595554).
CC       Interferes with secondary siRNA production by associating with host
CC       dsRNA-binding protein DRB4 (PubMed:30595554). Inhibits the host
CC       salicylic acid pathway during infection (PubMed:25387135).
CC       {ECO:0000269|PubMed:23377181, ECO:0000269|PubMed:25387135,
CC       ECO:0000269|PubMed:30595554}.
CC   -!- SUBUNIT: Interacts with host dsRNA-binding protein DRB4.
CC       {ECO:0000269|PubMed:30595554}.
CC   -!- SUBCELLULAR LOCATION: Secreted {ECO:0000305|PubMed:23377181}. Host cell
CC       {ECO:0000305|PubMed:23377181}.
CC   -!- INDUCTION: Expressed at specific infection stages in a transient manner
CC       (PubMed:25387135). Is not expressed until 24 hours post-infection (hpi)
CC       but quickly reaches the maximum expression level at approximately 36
CC       hpi (PubMed:25387135). The abundance of transcripts exhibits a more
CC       than twofold decrease at 48 hpi (PubMed:25387135).
CC       {ECO:0000269|PubMed:25387135}.
CC   -!- DOMAIN: The RxLR-dEER motif acts to carry the protein into the host
CC       cell cytoplasm through binding to cell surface phosphatidylinositol-3-
CC       phosphate. {ECO:0000305|PubMed:21653195}.
CC   -!- DOMAIN: The C-terminal region (residues 79 to 670) consists of seven
CC       imperfect tandem repeats, including one W-Y motif (WY1) and six L-W-Y
CC       motifs (LWY2 to LWY7) (Probable). WY1 forms a 3 alpha-helix fold with
CC       one hydrophobic core and each L-W-Y motif forms a highly conserved fold
CC       consisting of 5 alpha-helices (Probable). The units contribute
CC       differently to the virulence since WY1, LWY2 and LWY6 are important for
CC       the ability to suppress the biogenesis of small RNA in host and
CC       virulence activity of the pathogen, whereas LWY3, LWY4, LWY5 and LWY7
CC       are dispensable for PSR2 function (PubMed:30926664). WY1 and LWY2 are
CC       sufficient for association with DRB4, suppress gene silencing and
CC       promote infection (PubMed:30595554). These units may function as basic
CC       building blocks of Phytophthora effectors to enable virulence activity
CC       and accelerate the evolution of novel functions (Probable).
CC       {ECO:0000269|PubMed:30595554, ECO:0000269|PubMed:30926664,
CC       ECO:0000305|PubMed:30926664}.
CC   -!- DISRUPTION PHENOTYPE: Exhibits significantly decreased virulence when
CC       infecting soybean seedlings. {ECO:0000269|PubMed:23377181}.
CC   -!- SIMILARITY: Belongs to the RxLR effector family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; JN253932; AEK80745.1; -; Genomic_DNA.
DR   EMBL; JN253933; AEK80746.1; -; Genomic_DNA.
DR   EMBL; JN253934; AEK80747.1; -; Genomic_DNA.
DR   RefSeq; XP_009538063.1; XM_009539768.1.
DR   PDB; 5GNC; X-ray; 2.80 A; A=59-670.
DR   PDBsum; 5GNC; -.
DR   SMR; E0W4V5; -.
DR   GeneID; 20640800; -.
DR   KEGG; psoj:PHYSODRAFT_289089; -.
DR   HOGENOM; CLU_021192_3_0_1; -.
DR   OrthoDB; 717762at2759; -.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR   GO; GO:0043657; C:host cell; IEA:UniProtKB-SubCell.
DR   GO; GO:0009405; P:pathogenesis; IEA:UniProtKB-KW.
PE   1: Evidence at protein level;
KW   3D-structure; Glycoprotein; Repeat; Secreted; Signal; Virulence.
FT   SIGNAL          1..17
FT                   /evidence="ECO:0000255"
FT   CHAIN           18..670
FT                   /note="RxLR effector protein PSR2"
FT                   /id="PRO_5011089660"
FT   REPEAT          79..126
FT                   /note="WY1"
FT                   /evidence="ECO:0000305|PubMed:30926664"
FT   REPEAT          127..217
FT                   /note="LWY2"
FT                   /evidence="ECO:0000305|PubMed:30926664"
FT   REPEAT          218..308
FT                   /note="LWY3"
FT                   /evidence="ECO:0000305|PubMed:30926664"
FT   REPEAT          309..399
FT                   /note="LWY4"
FT                   /evidence="ECO:0000305|PubMed:30926664"
FT   REPEAT          400..492
FT                   /note="LWY5"
FT                   /evidence="ECO:0000305|PubMed:30926664"
FT   REPEAT          493..583
FT                   /note="LWY6"
FT                   /evidence="ECO:0000305|PubMed:30926664"
FT   REPEAT          584..670
FT                   /note="LWY7"
FT                   /evidence="ECO:0000305|PubMed:30926664"
FT   REGION          79..670
FT                   /note="7 X 93 AA tandem repeats"
FT                   /evidence="ECO:0000305|PubMed:30926664"
FT   MOTIF           39..54
FT                   /note="RxLR-dEER"
FT                   /evidence="ECO:0000305|PubMed:21653195"
FT   CARBOHYD        57
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00498"
FT   MUTAGEN         79..126
FT                   /note="Missing: In PSR2delta-WY1; reduces the ability to
FT                   suppress the biogenesis of small RNA in host and virulence
FT                   activity of the pathogen."
FT                   /evidence="ECO:0000269|PubMed:30926664"
FT   MUTAGEN         127..217
FT                   /note="Missing: In PSR2delta-LWY2; reduces the ability to
FT                   suppress the biogenesis of small RNA in host and virulence
FT                   activity of the pathogen."
FT                   /evidence="ECO:0000269|PubMed:30926664"
FT   MUTAGEN         218..308
FT                   /note="Missing: In PSR2delta-LWY3; does not Reduce the
FT                   ability to suppress the biogenesis of small RNA in host and
FT                   virulence activity of the pathogen."
FT                   /evidence="ECO:0000269|PubMed:30926664"
FT   MUTAGEN         309..399
FT                   /note="Missing: In PSR2delta-LWY4; does not Reduce the
FT                   ability to suppress the biogenesis of small RNA in host and
FT                   virulence activity of the pathogen."
FT                   /evidence="ECO:0000269|PubMed:30926664"
FT   MUTAGEN         400..492
FT                   /note="Missing: In PSR2delta-LWY5; does not Reduce the
FT                   ability to suppress the biogenesis of small RNA in host and
FT                   virulence activity of the pathogen."
FT                   /evidence="ECO:0000269|PubMed:30926664"
FT   MUTAGEN         493..583
FT                   /note="Missing: In PSR2delta-LWY6; reduces the ability to
FT                   suppress the biogenesis of small RNA in host and virulence
FT                   activity of the pathogen."
FT                   /evidence="ECO:0000269|PubMed:30926664"
FT   MUTAGEN         584..670
FT                   /note="Missing: In PSR2delta-LWY7; does not Reduce the
FT                   ability to suppress the biogenesis of small RNA in host and
FT                   virulence activity of the pathogen."
FT                   /evidence="ECO:0000269|PubMed:30926664"
FT   HELIX           77..85
FT                   /evidence="ECO:0007744|PDB:5GNC"
FT   HELIX           90..96
FT                   /evidence="ECO:0007744|PDB:5GNC"
FT   HELIX           103..106
FT                   /evidence="ECO:0007744|PDB:5GNC"
FT   HELIX           112..122
FT                   /evidence="ECO:0007744|PDB:5GNC"
FT   STRAND          123..125
FT                   /evidence="ECO:0007744|PDB:5GNC"
FT   HELIX           126..140
FT                   /evidence="ECO:0007744|PDB:5GNC"
FT   HELIX           143..155
FT                   /evidence="ECO:0007744|PDB:5GNC"
FT   HELIX           160..176
FT                   /evidence="ECO:0007744|PDB:5GNC"
FT   HELIX           181..187
FT                   /evidence="ECO:0007744|PDB:5GNC"
FT   TURN            188..192
FT                   /evidence="ECO:0007744|PDB:5GNC"
FT   HELIX           194..199
FT                   /evidence="ECO:0007744|PDB:5GNC"
FT   HELIX           202..216
FT                   /evidence="ECO:0007744|PDB:5GNC"
FT   HELIX           224..232
FT                   /evidence="ECO:0007744|PDB:5GNC"
FT   HELIX           234..246
FT                   /evidence="ECO:0007744|PDB:5GNC"
FT   TURN            248..250
FT                   /evidence="ECO:0007744|PDB:5GNC"
FT   HELIX           251..267
FT                   /evidence="ECO:0007744|PDB:5GNC"
FT   HELIX           272..278
FT                   /evidence="ECO:0007744|PDB:5GNC"
FT   HELIX           285..287
FT                   /evidence="ECO:0007744|PDB:5GNC"
FT   TURN            288..290
FT                   /evidence="ECO:0007744|PDB:5GNC"
FT   HELIX           292..307
FT                   /evidence="ECO:0007744|PDB:5GNC"
FT   HELIX           315..319
FT                   /evidence="ECO:0007744|PDB:5GNC"
FT   TURN            320..322
FT                   /evidence="ECO:0007744|PDB:5GNC"
FT   HELIX           325..337
FT                   /evidence="ECO:0007744|PDB:5GNC"
FT   HELIX           339..341
FT                   /evidence="ECO:0007744|PDB:5GNC"
FT   HELIX           342..359
FT                   /evidence="ECO:0007744|PDB:5GNC"
FT   HELIX           363..369
FT                   /evidence="ECO:0007744|PDB:5GNC"
FT   HELIX           372..374
FT                   /evidence="ECO:0007744|PDB:5GNC"
FT   HELIX           376..381
FT                   /evidence="ECO:0007744|PDB:5GNC"
FT   HELIX           385..394
FT                   /evidence="ECO:0007744|PDB:5GNC"
FT   TURN            400..402
FT                   /evidence="ECO:0007744|PDB:5GNC"
FT   HELIX           407..414
FT                   /evidence="ECO:0007744|PDB:5GNC"
FT   HELIX           419..430
FT                   /evidence="ECO:0007744|PDB:5GNC"
FT   HELIX           432..434
FT                   /evidence="ECO:0007744|PDB:5GNC"
FT   HELIX           435..451
FT                   /evidence="ECO:0007744|PDB:5GNC"
FT   HELIX           456..462
FT                   /evidence="ECO:0007744|PDB:5GNC"
FT   HELIX           465..467
FT                   /evidence="ECO:0007744|PDB:5GNC"
FT   HELIX           469..474
FT                   /evidence="ECO:0007744|PDB:5GNC"
FT   HELIX           477..489
FT                   /evidence="ECO:0007744|PDB:5GNC"
FT   HELIX           500..506
FT                   /evidence="ECO:0007744|PDB:5GNC"
FT   HELIX           510..521
FT                   /evidence="ECO:0007744|PDB:5GNC"
FT   HELIX           523..542
FT                   /evidence="ECO:0007744|PDB:5GNC"
FT   HELIX           547..553
FT                   /evidence="ECO:0007744|PDB:5GNC"
FT   TURN            554..557
FT                   /evidence="ECO:0007744|PDB:5GNC"
FT   TURN            561..565
FT                   /evidence="ECO:0007744|PDB:5GNC"
FT   HELIX           567..581
FT                   /evidence="ECO:0007744|PDB:5GNC"
FT   HELIX           590..598
FT                   /evidence="ECO:0007744|PDB:5GNC"
FT   HELIX           600..611
FT                   /evidence="ECO:0007744|PDB:5GNC"
FT   TURN            614..616
FT                   /evidence="ECO:0007744|PDB:5GNC"
FT   HELIX           617..633
FT                   /evidence="ECO:0007744|PDB:5GNC"
FT   HELIX           638..645
FT                   /evidence="ECO:0007744|PDB:5GNC"
FT   TURN            646..648
FT                   /evidence="ECO:0007744|PDB:5GNC"
FT   HELIX           651..669
FT                   /evidence="ECO:0007744|PDB:5GNC"
SQ   SEQUENCE   670 AA;  74613 MW;  44212A36D69674C0 CRC64;
     MRLQCVVLFA ALTLVAATHA PPNVKTVLSA EQHDIPVKRL LRPGNPAGKE DEERGINFSS
     VPGFEKLANL LKPKPGLKKL LKWADAKKPP ETVFTRLRLD KTGTQLFDNT DFPVWAAYTR
     SVAQTDSEAS AVMLKTLVSR YSDEVLSGMI AAAKKSSKTE SIATKLETEQ MRTWLAAKKT
     PDDMFLVFKL NKAGDDILSS PLLSAWTNYM KLSNKENPKA QTTLIATMTK HYGDSGVSQI
     LAAARKSPAT QSTAKRLEAE QVQLWLKKGR TPDDTFTLLS LDRAGDDLLA SPQFNTWMKY
     INYYNKENPD EKTTVLAKLM THFDDEELTP ILVVARKVPS TESTAAKLQA EQFKNWLSAD
     KSPEEAFTLL QLDKAGDDLL TNPQLTNWLK YTENFNLNKE INEQVTAIQV FRAQYVDDSR
     IANMVIAAEK VPNTQAIAKR VEDELFKGWT VVLNKPDDVF INLKLETVGE NVFESPLWSF
     YTKFLEKYNT ANPGKEQTMI SGLARGYNDV TLTNMLLKAK EAPSTKTLAT KLEDELVQYW
     LADKKLPDKL FGYLELKESV DGILTNPVFN VWLKYLNAFN DKAPVKKALM IDTLKSAFGD
     VAVSNMLFAA KKDPGTAKVA ATLQTALLSK WVLEKKTPGQ VSAILKEGAG ADVSAKLLAT
     YSAKFKVRWG
//
